About the handling of Minamata disease-related notebook accompanied with start (from January, 2015) of new intractable disease measures
[to notebook owner and all of the medical institutions] About the handling of number, public expenditure person number according to law of Minamata disease-related notebook (medical notebook, Minamata disease victim notebook)
In Kumamoto, we carried out Minamata disease synthesis measures medical care business and health influence research business pertaining to methylmercury for the purpose of reduction of health problem of Minamata disease victims, but new intractable disease measures were started in January, 2015, and many diseases handled as specific disease of number "51" according to law were changed to number "54" according to law.
Therefore as there is not change, or, about "medical care notebook by health influence research business pertaining to methylmercury", have inquiry from number according to law and person of public expenditure number, but "medical care notebook" and "Minamata disease victim notebook" which number according to law is the same, and are "51" are systems that are different from this intractable disease measures about Minamata disease relations notebook, accompanied with this system revision there is no change.
In addition, you can use current notebook and person of public expenditure number (number according to law) sequentially as update of identification of recipient (notebook) does not go.
If you have any questions, please consult to the following window.
We would appreciate your cooperation continuously.
Point to keep in mind at the time of request for receipt
○When Minamata disease-related public expenditure medical care business (medical notebook, Minamata disease victim notebook, medical notebook by healthy influence research business pertaining to methylmercury) is applied, copayment of medical service under health insurance is the total amount public money.
(there is not difference in self-pay limit with change of self-pay ratio and income division.)
○In addition, after this system change, there is no change in priority and range of public money application about Minamata disease-related public expenditure medical care business.
(please consult about any unclear points to the following window.)